Related Experiment Video
Updated: Jun 16, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
[Clinical study of Wenxikeli treatment of viral myocarditis]
1The People's Liberation Army, General Hospital, The First Affiliated Hospital of Heart Medicine, Beijing 100037, China.
Objective:
To observe Wenxinkeli viral myocarditis clinical efficacy and safety.
Methods:
45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks.
Results:
The treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05).
Conclusions:
Wenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis IV: Nursing Management